TELA Bio (TELA) Return on Equity (2019 - 2026)

TELA Bio has reported Return on Equity for 8 years, with the latest figure at 0.72% in Q1 2026.

• For the quarter ending Q1 2026, Return on Equity fell 72.0% year-over-year to 0.72%; the trailing twelve-month figure through Mar 2026 stood at 0.72% (down 72.0% YoY), and the FY2025 full-year result was 0.02%, down 2.0% from the prior year.
• Return on Equity for Q1 2026 stood at 0.72%, down from 0.1% in the prior quarter.
• The five-year high for Return on Equity was 0.25% in Q3 2024, with the low at 0.72% in Q1 2026.
• Average Return on Equity over 5 years is 0.06%, with a median of 0.02% recorded in 2022.
• Year-over-year, Return on Equity advanced 26 bps in 2024 and sank 72 bps in 2026.
• Tracing TELA's Return on Equity over 5 years: stood at 0.02% in 2022, then grew by 13 bps to 0.02% in 2023, then soared by 103 bps to 0.0% in 2024, then slumped by 18088 bps to 0.1% in 2025, then tumbled by 626 bps to 0.72% in 2026.
• The last three Return on Equity figures came in at 0.72% (Q1 2026), 0.1% (Q4 2025), and 0.0% (Q3 2025), per Business Quant data.

Peer Comparison